![]() |
|
Medical historians have found descriptions of cases compatible with the diagnosis of Multiple Sclerosis (MS) for centuries. As early as the 14th Century, the life story of St. Lidwina of Schiedam (1430 -1433) described neurological complaints similar to MS. The letters and diaries of Sir Augustus Frederic d’Este (1794 - 1848), grandson of George III of England and the nephew of Queen Victoria, probably give the best literary account of MS: a disorder that lasted for 25 years and was characterized by symptoms that are commonly experienced by MS patients today.Back to TopJean M. Charcot, French Neurologist (1825- 1893), was the first physician to report a patient who presented with speech disturbances, abnormal eye movements and tremors ("Charcot’s triad"). Charcot recognized that these symptoms were specific and different from any other neurological disorder. He observed this patient for many years and the diagnosis of MS was made at autopsy. He was the first to use the term "scerosis en plaques" (MS) We now know that MS symptoms described by Charcot only occur in very severe and advanced cases of MS.
Back to TopGender Ratio
- MS is slightly more common in females than males (ratio 3:2)
Age of Onset
- MS is a disease that affects young adults. The onset of symptoms is usually between the ages of 15 years to 45 years, but cases have been reported in children under 10 years of age and in adults over 59 years of age.
MS is largely a disease of Caucasians of central and northern European ancestry. Prevalence studies, i.e., the ascertainment of a number of MS cases in a defined area on a given date, he concluded that the worldwide distribution is influenced by latitude and racial origin. High prevalence areas for MS include those in extreme latitudes and temperate climates, e.g., northern and central Europe, northern North America, New Zealand and southern Australia. MS is less common ( i.e., low prevalence rate) closer to the equator and in hot climates. It is thought that the migration of Europeans to North America may account for the high frequency of MS in Canada and northern U.S. Native Black Africans and Orientals have a low prevalence when living in their countries or origin; but their risk to develop MS changes slightly when they move to a high risk country. This risk increases more with the admixture of Caucasian genes through intermarriage.Back to TopThroughout most of Canada, including British Columbia, recent studies have found a prevalence rate of about 1/1000 or 0.1%
The cause of MS is unknown. Environmental, genetic and epidemiological factors all play an important role in a person’s predisposition for MS. The immune system of individuals with MS may also be a factor. An immune response is the body’s ability to react to a specific foreign agent (virus, bacteria). An autoimmune response occurs when the body goes "haywire" and reacts against its own tissues. In MS this would be a an attack on the central nervous system. Cells of lymphoid tissue initiate and control the immune response. Studies on peripheral blood have shown abnormality in lymphocyte function during an MS attack and in the chronic progressive phase of the disease.Back to TopIn epidemiological studies, a viral cause has always been considered, but no virus has been isolated. It is known that all viruses behave differently and the immune response to infection can vary from benign to severe. It is possible that a virus affects only those who are genetically susceptible. Once this infection occurs, the body reacts as expected but then a slow abnormal immune response develops and leads to an ongoing autoimmune response. The theory of the slow or latent virus has also been considered . This virus would remain dormant in the central nervous system of the host individual for 10 to 20 years and then produce an immune response. Family data, including very recent work on adoptees with MS, do not support the hypothesis of a transmissible viral agent being responsible for MS.
Sometime the damage is permanent and conduction of messages are not restored. In general, the longer a person has clinical MS, the less likely a complete remission will occur.Back to Top
Back to TopMotor symptoms
"Heaviness" of a limb Weakness of legs and arms Difficulty walking Inability to move a limb - paralysis of limbs/limb Facial weakness Spasticity of limbs - "stiffness, "jerkiness", "involuntary shaking" Loss of balance leading to difficulty walking Incoordination Tremors interfering with dexterity and speech Sensory Symptoms
Tingling, numbness, "pins and needles" Tightness of a limb Girdle sensation of trunk Hot and cold sensations Facial pain (Trigeminal Neuralgia) Pain - burning sensation in extremities Electric shock sensation in the back, arms and legs with neck flexion (Lhermitte’s sign) Visual SymptomsBlurred vision Loss of central vision - associated with pain/tenderness of eye Weakness of eye muscles resulting in double vision Abnormal eye movements Other symptoms
Bladder dysfunction - frequency, urgency, retention, hesitancy, loss of control, frequent voiding at night. Bowel problems - constipation’s, urgency, loss of control. Fatigue - feeling of overwhelming weakness, tiredness, lack of energy, and listlessness all resulting in inability to function. Sexual dysfunction - abnormal genital function resulting in difficulties in attaining and maintaining an erection in males, ejaculation may be retrograde into the bladder. Problems with lubrication and achieving orgasm in females. Dizziness - feeling of turning or spinning often accompanied by nausea or vomiting. Mood changes - feelings of frustration, irritability, depression, or euphoria. Memory - forgetfulness, problems with concentrations and abstract thinking, or memory loss.
Always research__ never take just one persons view even if that person is a physician__ Learn all you can before you decide on any treatment!
|
Information provided at this web site is of a general nature and is not intended to take the place of a physician's adivice It is vital that persons diagnosed with, or suspected of having, an autoimmune disease consult with their physician or with the appropriate division at a major teaching hospital, to assure proper evaluation, treatment and interpretation of information contained on this site. © Copyright 1998: Permission is hereby granted to MS Societies and all MSers to publish information from these pages provided that no financial reward is gained and attribution is given to the author/s. |